Clinical trial Recruiting at 1 site Interventional Ages 18 to 30

Preventive behavioral intervention for young adults with psychotic experiences

Official title: A Randomized Controlled Trial of a Preventive Behavioral Intervention for Young Adults With Psychotic Experiences

Run by Massachusetts General Hospital · NCT06929442 · Data updated 2026-11-12

This study is testing if a new Resilience Training program can help college freshmen and sophomores who are at risk for serious mental illnesses feel better and prevent issues like psychosis, mood swings, and anxiety.

Quick facts

Study typeInterventional
Ages18 Years to 30 Years
SexAll
Enrollment192 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Charlestown, Massachusetts)
StatusRecruiting
StartedFebruary 10, 2025
Main results expectedDecember 1, 2028
Study endsJune 2029
Registry record updatedMay 11, 2026
Trial IDNCT06929442 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are college students aged 18-30 who have reported some psychotic experiences.

Probably not a fit

Patients currently experiencing active psychiatric symptoms or those receiving psychological treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of Resilience Training in college students who are at an elevated risk for developing serious mental illnesses. Participants, aged 18-30 and enrolled as freshmen or sophomores, will be randomly assigned to receive either Resilience Training or Life Skills Training. The study aims to assess how these interventions can help mitigate the onset of psychotic disorders, mood disorders, and anxiety disorders in this vulnerable population.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce the risk of developing serious mental illnesses among young adults.

How similar studies have gone: Other studies have shown promise in using resilience training for mental health prevention, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. 18-30 years old
2. Enrolled as a first or second year student (i.e., freshman or sophomore) in an undergraduate program at the college or university where the intervention takes place
3. Students who endorse some psychotic experiences (Peter's et al. Delusion Inventory (PDI) score \> 3)

Exclusion criteria:

1. Inability to provide informed consent
2. Not proficient in English
3. Current self-reported Diagnostic Statistical Manual 5 (DSM-5) diagnosis with active symptoms (such as active psychotic symptoms, current suicidality, serious active alcohol or substance use, marked deterioration in functioning over the prior month) determined by clinical interview with participant, or self-report of a psychiatric diagnosis that necessitates close monitoring or individual therapy and/or inpatient or partial hospitalization
4. Current enrollment in psychological or behavioral health treatment.
5. Current use of psychotropic medications (other than stimulants) prescribed by a physician.
6. A diagnosis of a serious, chronic mental illness as determined by the Mini-International Neuropsychiatric Interview (MINI)

Where it's running

  • Massachusetts General Hospital
    Charlestown, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.